ES8601193A1 - Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles - Google Patents

Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles

Info

Publication number
ES8601193A1
ES8601193A1 ES529369A ES529369A ES8601193A1 ES 8601193 A1 ES8601193 A1 ES 8601193A1 ES 529369 A ES529369 A ES 529369A ES 529369 A ES529369 A ES 529369A ES 8601193 A1 ES8601193 A1 ES 8601193A1
Authority
ES
Spain
Prior art keywords
alkyl
formula
group
benzisoxazoles
piperidyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529369A
Other languages
English (en)
Other versions
ES529369A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8601193A1 publication Critical patent/ES8601193A1/es
Publication of ES529369A0 publication Critical patent/ES529369A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 3-(4-PIPERIDIL)-12-BENCISOZASOLES. CONSISTE EN CICLISAR UN COMPUESTO DE FORMULA (II) CONVIRTIENDO PREVIAMENTE EL COMPUESTO EN SU DERIVADO DE OXIMA Y CICLISANDOLO SIN AISLAMIENTO EN PRESENCIA DE UNA BASE DESALCOHILAR O DEBENCILAR EL COMPUESTO DE FORMULA (I) DONDE R ES ALCOHILO O BENCILO PARA OBTENER UN COMPUESTO DE FORMULA (III) AL QUE SE HIDROLIZA POR MEDIO DE HIDROXIDO ALCALINO PARA DAR UN COMPUESTO DE FORMULA (I) DONDE R ES H O TRATAR EL COMPUESTO DE FORMULA (I) DONDE R ES EL GRUPO BENCILOXICARBONILO CON HALURO DE HIDROGENO EN UN ACIDO ALCANOICO PARA PROPORCIONAR UN COMPUESTO DE FORMULA (I) DONDE R ES H Y HACER REACCIONAR ESTE CON UN HALURO DE ALCOHILO INFERIOR Y OTROS PARA PROPORCIONAR COMPUESTOS DE FORMULA (I) EN LA QUE R ES ALCOHILO INFERIOR ALQUENILO INFERIOR Y OTROS.
ES529369A 1981-11-12 1984-02-01 Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles Granted ES529369A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/319,871 US4355037A (en) 1981-11-12 1981-11-12 3-(4-Piperidyl)-1,2-benzisoxales

Publications (2)

Publication Number Publication Date
ES8601193A1 true ES8601193A1 (es) 1985-09-16
ES529369A0 ES529369A0 (es) 1985-09-16

Family

ID=23243957

Family Applications (3)

Application Number Title Priority Date Filing Date
ES517245A Expired ES8405791A1 (es) 1981-11-12 1982-11-10 Un procedimiento para la preparacion de 3-(4-piperidil)-1,2-bencisoxazoles.
ES529370A Granted ES529370A0 (es) 1981-11-12 1984-02-01 Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles
ES529369A Granted ES529369A0 (es) 1981-11-12 1984-02-01 Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES517245A Expired ES8405791A1 (es) 1981-11-12 1982-11-10 Un procedimiento para la preparacion de 3-(4-piperidil)-1,2-bencisoxazoles.
ES529370A Granted ES529370A0 (es) 1981-11-12 1984-02-01 Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles

Country Status (11)

Country Link
US (1) US4355037A (es)
EP (1) EP0080104B1 (es)
JP (1) JPS5890582A (es)
KR (1) KR880002012B1 (es)
AT (1) ATE39251T1 (es)
AU (2) AU567865B2 (es)
CA (1) CA1215066A (es)
DE (1) DE3279282D1 (es)
ES (3) ES8405791A1 (es)
IE (1) IE54857B1 (es)
ZA (1) ZA828281B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835177A (ja) * 1981-08-26 1983-03-01 Dainippon Pharmaceut Co Ltd ２−環状アミノ−２−（１，２−ベンズイソキサゾ−ル−３−イル）酢酸エステル類並びにその酸付加塩類および第４級アンモニウム塩類
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4408054A (en) * 1981-11-12 1983-10-04 Hoechst-Roussel Pharmaceuticals Inc. Oximes of 4-benzoyl-piperidines
US4528376A (en) * 1982-08-11 1985-07-09 Hoechst-Roussel Pharmaceuticals Inc. 3-(4-Piperidyl)-1,2-benzisoxazoles
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles
US4528292A (en) * 1984-04-23 1985-07-09 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive 1,2-benzisothiazole piperidines
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
DE3677609D1 (de) * 1985-01-23 1991-04-04 Hoechst Roussel Pharma 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
US5057611A (en) * 1985-04-22 1991-10-15 Hoechst-Roussel Pharmaceuticals Inc. Benzoylpiperidines
EP0243184A3 (en) * 1986-04-25 1989-05-10 Roussel-Uclaf Pesticidal compounds
JPS63185141A (ja) * 1987-01-27 1988-07-30 Daikin Ind Ltd 空気調和機のデ−タ伝送方式
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
GR1000667B (el) * 1988-03-21 1992-09-25 Janssen Pharmaceutica Nv Μεθοδος παρασκευης 3-πιπεριδινυλο-1,2-βενζισοξαζολων.
FR2641278B1 (fr) * 1989-01-05 1991-03-22 Lipha Piperidines, procedes de preparation et medicaments les contenant
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
FR2654104B1 (fr) * 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ236501A (en) * 1989-12-21 1992-12-23 Merrell Dow Pharma Piperidine derivatives and antithrombotic compositions
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5055476A (en) * 1990-08-13 1991-10-08 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
US7125903B1 (en) * 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
ATE264329T1 (de) 2000-05-05 2004-04-15 Rpg Life Sciences Ltd Verfahren zur herstellung von antipsychotischem 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-
CN111518019B (zh) * 2019-02-01 2023-10-24 江苏豪森药业集团有限公司 一种棕榈酸帕里哌酮中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517695A (en) * 1945-07-13 1950-08-08 Ciba Pharm Prod Inc Production of 1-alkyl 4-phenylpiperidyl 4-ketones
JPS5545545B2 (es) * 1972-03-17 1980-11-18
DE2245971A1 (de) * 1972-07-13 1974-03-14 Merck Patent Gmbh Isoxazolderivate und verfahren zu ihrer herstellung
US4217349A (en) * 1974-07-01 1980-08-12 Sumitomo Chemical Company, Limited Benzisoxazole derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles

Also Published As

Publication number Publication date
ES8507519A1 (es) 1985-09-01
ES529370A0 (es) 1985-09-01
CA1215066A (en) 1986-12-09
ES517245A0 (es) 1984-06-16
EP0080104A2 (en) 1983-06-01
ZA828281B (en) 1983-09-28
EP0080104B1 (en) 1988-12-14
IE822684L (en) 1983-05-12
ES8405791A1 (es) 1984-06-16
EP0080104A3 (en) 1983-08-24
JPS5890582A (ja) 1983-05-30
KR880002012B1 (ko) 1988-10-12
AU9039082A (en) 1983-05-19
AU1138588A (en) 1988-05-19
JPH0411546B2 (es) 1992-02-28
KR840002377A (ko) 1984-06-25
AU567865B2 (en) 1987-12-10
ATE39251T1 (de) 1988-12-15
DE3279282D1 (en) 1989-01-19
ES529369A0 (es) 1985-09-16
IE54857B1 (en) 1990-02-28
US4355037A (en) 1982-10-19
AU612621B2 (en) 1991-07-18

Similar Documents

Publication Publication Date Title
CA1136549A (en) Combination of thienamycin-type antibiotics with dipeptidase inhibitors
IL81234A (en) Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
CA2089767A1 (en) Pyridinyl thiadiazolyl- and oxadiazolyl derivatives
EP0282547B1 (en) Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
NO942376L (no) Terapeutiske midler
EP0498331B1 (en) N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3.2.1)octanes, intermediates and a process for the preparation thereof and their use as medicaments
ES8104991A1 (es) Procedimiento para la preparacion de 4-fenoxipiperidinas
JPS5777689A (en) Novel cephen compound, or its salt, its preparation, and preventive it as active ingredient
AU2002327172B8 (en) Substituted 1-benzazepines and derivatives thereof
US5190953A (en) Heterocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents
ZA958669B (en) Diazepino-indoles inhibitors of phosphodiesterases iv
AU2002327172A1 (en) Substituted 1-benzazepines and derivatives thereof
US6514965B1 (en) Substituted 1-benzazepines and derivatives thereof
MY103502A (en) Novel compounds
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
JPS57142972A (en) Carbostyril derivative
EP0655246A1 (en) Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
GB1573580A (en) Pharmaceutical cardioactive compositions containing pteridine derivatives
IE63194B1 (en) Antiemesis ergoline derivatives
ZA936393B (en) Novel oxazolidines
WO2002007714A2 (en) Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
JPS56138169A (en) Compound related to g-6302 and its preparation
CA2079361A1 (en) Use of 4-amino-1-(2-pyridyl)piperidines as anti-convulsant and antiepileptic agents

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303